D.E. Shaw & Co
VMD icon

D.E. Shaw & Co’s Viemed Healthcare VMD Stock Holding History

D.E. Shaw & Co’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,322
Closed -$93.2K – 4900
2022
Q4 		$93.2K Sell
12,322
-42,538
-78% -$288K ﹤0.01% 4376
2022
Q3 		$330K Sell
54,860
-161,806
-75% -$1.04M ﹤0.01% 4258
2022
Q2 		$1.17M Sell
216,666
-62,727
-22% -$338K ﹤0.01% 3520
2022
Q1 		$1.4M Buy
279,393
+122,338
+78% +$568K ﹤0.01% 3627
2021
Q4 		$820K Sell
157,055
-19,717
-11% -$110K ﹤0.01% 4092
2021
Q3 		$981K Buy
176,772
+31,556
+22% +$205K ﹤0.01% 3617
2021
Q2 		$1.04M Buy
145,216
+20,110
+16% +$174K ﹤0.01% 3497
2021
Q1 		$1.27M Buy
125,106
+73,537
+143% +$692K ﹤0.01% 2923
2020
Q4 		$400K Buy
+51,569
New +$454K ﹤0.01% 3492

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $661M AUM 63.05% 1-Year Est. Return

D.E. Shaw & Co's VMD Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Viemed Healthcare (VMD) in Q1 2023, closing a stake of 12,322 shares — an estimated $93.2K sold.

D.E. Shaw & Co first reported a position in VMD in Q4 2020 and held it in 9 quarters. The position peaked at $1.4M in Q1 2022. 88 funds tracked by Wall St. Rank hold VMD as of Q1 2023.

  • D.E. Shaw & Co reported no remaining Viemed Healthcare position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 12,322 Viemed Healthcare shares in Q1 2023, an estimated $93.2K.
  • D.E. Shaw & Co first reported a position in Viemed Healthcare in Q4 2020 and held it in 9 quarters.
  • D.E. Shaw & Co's Viemed Healthcare position peaked at $1.4M in Q1 2022.
  • 88 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.